#Oncology — FinScans

Release 📈 Stocks

miRoncol Health Launches Canada's First miRNA Multi-Cancer Screening Test

October 1, 2026 (33 days ago)

miRoncol Health introduces miCheckup, a novel miRNA-based blood test designed to detect early-stage cancer signals, expanding the landscape of Canadian diagnostic screening…

miRoncol Health

🌍 AMERICAS Read More →

Release 📈 Stocks

SkinCure Oncology Hits 150,000 Patient Milestone for GentleCure Treatment

September 28, 2026 (35 days ago)

SkinCure Oncology reports 150,000 patients treated with its GentleCure IGSRT technology, underscoring the firm's growing commercial presence in the nonmelanoma skin cancer…

SkinCure Oncology

🌍 AMERICAS Read More →

Release 📈 Stocks

Biohaven Shares Eye Gains as BHV-1530 Data Selected for ENA 2026 Presentation

September 28, 2026 (36 days ago)

Biohaven's BHV-1530 Phase 1 study data will be presented at the ENA 2026 symposium, marking a significant clinical milestone for the company's…

BHVN

🌍 AMERICAS Read More →

Release 📈 Stocks

Innovent Biologics Expands Phase 3 MarsLight-11 Study for NSCLC Treatment

September 28, 2026 (36 days ago)

Innovent Biologics broadens the scope of its Phase 3 MarsLight-11 study, targeting a wider patient population for its IBI363/TAK-928 oncology candidate to…

01801.HK

🌍 ASIA Read More →

Release 📈 Stocks

Leo Cancer Care Secures Clinical Clearance for Upright Radiotherapy Platform

September 27, 2026 (37 days ago)

Leo Cancer Care's upright radiotherapy platform gains clinical clearance, marking a pivotal transition from conceptual design to practical application in oncology treatment.

Leo Cancer Care

🌍 AMERICAS Read More →

News 📈 Stocks

GSK China Deals Surge as Biotech IPOs Hit $300M Milestone

September 19, 2026 (45 days ago)

GSK accelerates China-focused oncology licensing, Electra Therapeutics joins a record-setting cohort of large-scale biotech IPOs, and Scholar Rock faces a sell-the-news reaction…

SRRK GSK ELTA +4

🌍 GLOBAL Read More →

News 📈 Stocks

Caris Life Sciences Rallies 10% as Precision Oncology Sector Gains Momentum

September 19, 2026 (45 days ago)

Caris Life Sciences shares climbed 10% in a sector-wide rally, leaving the stock trading above analyst price targets as investors weigh decelerating…

CAI TEM MRNA

🌍 AMERICAS Read More →

News 🌐 Macro — 📊 Neutral

BlossomHill Therapeutics Shares Rally 4.4% on Positive Lung Cancer Trial Data

September 17, 2026 (47 days ago)

BlossomHill Therapeutics stock gains 4.4% as the company reports a 45% objective response rate for its BH-30643 lung cancer treatment in the…

Geron Raises 2026 RYTELO Revenue Outlook to $230M-$240M on Strong Adoption

September 16, 2026 (48 days ago)

Geron reports record quarterly revenue of $57.5 million and raises its 2026 RYTELO revenue guidance to $230M-$240M as the company accelerates its…

GERN

🌍 AMERICAS Read More →

News 📈 Stocks

Champions Oncology Revenue Climbs 9% as Q1 EBITDA Hits $671,000

September 12, 2026 (52 days ago)

Champions Oncology posted a 9% revenue increase to $15.2 million in Q1 fiscal 2027, driven by improved service margins and a surge…

CSBR

🌍 AMERICAS Read More →

News 📈 Stocks

Moderna Shares Surge 499% Over 52 Weeks on Cancer Vaccine Breakthrough

September 9, 2026 (55 days ago)

Moderna stock maintains strong bullish momentum, surging 499.5% annually after its cancer vaccine trial met key clinical goals, leaving sector peers like…

MRNA XLV MRK

🌍 NORTH AMER Read More →